Healing Investigational

TB-500 Fragment

Also known as: Tβ4 Active Fragment, Thymosin Beta-4 Minimal Sequence

A concentrated fragment of Thymosin Beta-4 focused on the core actin-binding domain — smaller molecule, targeted tissue repair.

Popularity B
Class Thymosin Beta-4 Fragment
Half-Life ~2-3 hours
Form Lyophilized powder
Jump to Dosing ↓
TB500 thymosin beta4 peptide vial used for recovery and healing research
Research-Backed User Reports Sourced Updated Mar 2026
// Overview

What is TB-500 Fragment?

TB-500 Fragment represents a further refinement of the Thymosin Beta-4 peptide family. While TB-500 itself is a fragment of the full 43-amino acid Thymosin Beta-4 protein, TB-500 Fragment isolates an even more specific active region to concentrate the cell migration and tissue repair effects.

The fragment approach has several theoretical advantages: higher molar concentration of the active binding domain per milligram, potentially improved tissue penetration due to smaller molecular size, and more targeted biological activity with fewer off-target effects.

TB-500 Fragment is part of a growing trend in peptide science toward identifying minimal active sequences that retain full therapeutic potency while reducing molecular complexity. This approach has been validated with other peptides like KPV (a fragment of α-MSH) and AOD-9604 (a fragment of HGH).

Found this helpful?

Join our newsletter for compound breakdowns, dosing protocols, and research updates.

Free forever. No spam. Unsubscribe anytime.

// How It Works

How TB-500 Fragment Works

TB-500 Fragment retains the core actin-binding mechanisms of Thymosin Beta-4:

  1. Actin sequestration — The LKKTETQ motif binds G-actin monomers, regulating actin polymerization dynamics that control cell shape, motility, and migration.
  2. Cell migration — By modulating the actin cytoskeleton, the fragment promotes directional cell migration toward injury sites — fibroblasts for tissue repair, immune cells for defense, and endothelial cells for blood vessel formation.
  3. Anti-inflammatory — Retains Thymosin Beta-4's ability to suppress inflammatory cytokines and promote the transition from inflammatory to repair/remodeling phases of healing.
  4. Smaller size advantage — Reduced molecular weight may improve tissue penetration and bioavailability per mole of active sequence.
// Dosage Protocols

Dosage Information (User-Reported)

Disclaimer: Dosage information is compiled from user reports and published research. This is not medical advice. Consult a healthcare professional before use.
Level Dose Frequency Duration
Standard 750 mcg - 1.5 mg 2x per week 4-8 weeks
Acute Injury 1-2 mg 2-3x per week 2-4 weeks
Maintenance 500 mcg - 1 mg 1-2x per week Ongoing

What to Expect

Week 1-2

Reduced inflammation at injury sites. Improved flexibility. Subtle healing acceleration.

Week 3-4

Tissue repair becoming evident. Chronic injuries improving. Range of motion better.

Week 5-8

Significant healing progress. Similar effects to full TB-500 at potentially lower doses.

Note

Limited comparative data vs full TB-500. Most user reports suggest similar efficacy profile.

Common Stacks

BPC-157

Complementary Healing

Fragment handles cell migration while BPC-157 provides growth factor signaling

GHK-Cu

Collagen Support

Fragment delivers cells to repair sites, GHK-Cu provides structural protein synthesis

KPV

Anti-Inflammatory Base

KPV controls inflammation while the fragment drives tissue remodeling

// Preparation

Reconstitution & Storage

Reconstitute with bacteriostatic water per vendor instructions. Smaller molecular weight may allow for more concentrated dosing. Inject slowly, do not shake.

Storage: Lyophilized: 2-8°C. Reconstituted: 2-8°C, use within 21 days.
// Safety Profile

Side Effects & Safety

Potential Side Effects

  • ! Injection site irritation
  • ! Mild lethargy
  • ! Headache (uncommon)
  • ! Generally well tolerated — expected to have similar or milder side effects than full TB-500

Contraindications

  • ⚠ Active malignancy
  • ⚠ Pregnancy or breastfeeding
  • ⚠ Known hypersensitivity to thymosin peptides
  • ⚠ Active internal bleeding

Legal & Regulatory Status

Not FDA-approved. Research peptide. Not a controlled substance. Available from select peptide vendors.

// Research

Published Research

// Related Compounds

Other Healing Guides

Subcutaneous injection technique pinching abdominal skin fold for peptide admini

Cagrilintide

A long-acting amylin analog that amplifies weight loss when paired with semaglutide — the amylin component of CagriSema's…

Read Guide →
Lyophilized BPC157 powder as a white cake inside a sealed vial

BPC-157 Arginate (Oral)

The oral form of BPC-157 — gastric-acid stable and designed for direct GI tract healing. No injections needed…

Read Guide →
Biomarker dashboard on a computer screen tracking health metrics over time

5-Amino-1MQ

An NNMT inhibitor that restores NAD+ in fat cells, shifting adipose tissue from storage mode back to metabolically…

Read Guide →

Stay informed on TB-500 Fragment.

New research, dosage updates, and protocol breakdowns. Straight to your inbox.

Free forever. No spam. Unsubscribe anytime.

This content is for informational and educational purposes only. TB-500 Fragment is sold for research purposes. Never Natty does not condone or encourage the use of any substance in violation of any laws. Consult a healthcare professional before using any compound discussed on this site.